At the headquarters of IRBLleida, member of CataloniaBio & HealthTech, the second edition of Agrohealth, the call for research projects in Agriculture, Food, Nutrition and Health of Agrotecnio and IRBLleida, has been presented. 

Theriva Biologics, member of CataloniaBio & HealthTech, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to lead clinical candidate VCN-01 in combination with gemcitabine and nab-paclitaxel to improve progression-free survival and overall survival in patients with metastatic pancreatic adenocarcinoma.  

CataloniaBio & HealthTech, powered by the Internal Digital Committee, organised a round table at the 2024 edition of the Health Revolution Congress, the digital health congress promoted by BHH that brings together global startups and stakeholders in Barcelona to explore the digital health solutions of the future. More than thirty people filled the room, a full house showing the interest on the sessions.

Abzu, member of CataloniaBio & HealthTech, announced the appointment of Victor Galindo, as its new Chief Executive Officer. Victor, a co-founder of Abzu and previously Abzu’s Chief Technology Officer, succeeds Casper Wilstrup, who has been steering the company since 2018. 

Cellab CDMO, member of CataloniaBio & HealthTech, has been awarded a GMP certificate as manufacturer of advanced therapy products under the European Union (EU) standards. The AEMPS has been the entity in charge of certifying compliance with these standards. 

On 24 April we connected to the fourthsession of the ‘GO International’ series, a series of webinars organised byCataloniaBio & HealthTech where different international destinations areproposed to learn more about their health systems. Through contact with otherclusters, associations, companies or institutions, experts share details aboutentities of the ecosystem of that location, regulatory barriers or evenopportunities for entry and commercialisation in those markets, and offerconnection paths.

Dr. Manel Esteller, director of the Josep Carreras Leukaemia Research Institute (IJC), member of CataloniaBio & HealthTech, has been selected as the top researcher in the field of genetics in Spain in the 2024 edition of the Research.com ranking of the best scientists, a leading academic platform for researchers. He has also obtained the 37th position among the 4,000 best scientists in the world studying genetics. 

LAINCO, member of CataloniaBio & HealthTech, commemorated its 90th anniversary since its founding in 1934. The celebration took place from April 29 to May 3 and included a series of outstanding events that brought together clients, distributors and staff in an unforgettable celebration. 

Dentaid, member of CataloniaBio & HealthTech, presents an informative document on-gum health to dispel false myths. It has presented an informative document on gum health on World Gum Day, which was celebrated on May 12th.  

ACESABIO was officially constituted at the end of 2023, as an association that is positioned at all stages of the process. CataloniaBio & HealthTech is one of the 12 clusters that form part of this alliance, with a representation that allows it to understand the needs and challenges at each stage and in each territory, facilitating collaboration between actors. Moreover, by being a benchmark throughout the chain, it can drive innovation in a holistic way and promote synergies between the various actors.

The second edition of Connection Day, a working day that has already become a benchmark for the ecosystem, was attended by more than 560 participants, including 155 companies and institutions and 56 exhibiting companies, as well as 268 B2B meetings. "The main objective of this annual meeting is to create a space that facilitates the exchange of knowledge, gives visibility to both the opportunities and needs of companies and organisations and, in short, is a space where participants can explore synergies and establish points of collaboration," says Javier Selva, CEO of CataloniaBio & HealthTech.

After two years of euphoria, 2023 reflected a correction in the investment market that tied up most of the capital. However, investors predict an increase in the number and quality of operations for 2024, according to Study on investment in the Life Sciences and Healthcare industry in Catalonia 2023, prepared by CataloniaBio & HealtTech and EY, and presented today as part of the second edition of Connection Day, in La Farga de L'Hospitalet de Llobregat.

REIG JOFRE, member of CataloniaBio & HealthTech, hosted a visit at its state-of-the-art plant to produce hospital-use injectable drugs, from the Minister of Industry and Tourism, Jordi Hereu Boher, accompanied by Jordi García Brustenga, Director General of Industrial Strategy and Small and Medium Enterprises; and the mayor of Sant Joan Despí, Belén García. 

G&L Healthcare Advisors has announced the appointment of Dr. Steven Hildemann, MD, PhD, as a Non-Executive Director. Acting in an advisory capacity, Dr. Hildemann will bring his invaluable expertise to G&L as the company continues to expand globally and pursue strategic acquisitions. 

Ysios Capital, member of CataloniaBio & HealthTech, has announced its participation in the Swiss company MEMO Therapeutics funding round expansion of 20 million Swiss Francs (€20.5M). 

Longevitas Labs, the first Spanish laboratory specialized in aging prevention, partners with Made of Genes, member of CataloniaBio & HealthTech, to present the innovative Personalized Bio-Genetic Study. 

SocialDiabetes, member of CataloniaBio & HealthTech, announces the launch of "Listen.Doctor", an AI-powered tool that transforms medical consultations into actionable knowledge. 

Google.org has announced that it will invest 200,000 euros in an artificial intelligence (AI) project focused on improving cancer patients called GrowAI by HumanITcare, member of CataloniaBio & HealthTech. 

The BC Link platform, developed by the biotechnology company Better Care, member of CataloniaBio & HealthTech, will be the first technology to be evaluated using the parameters agreed upon by all participants in the ASSESS-DHT project, which aims to standardize and harmonize the evaluation of Digital Health Technologies across Europe. 

CataloniaBio & HealthTech is launching a new space for analysing current affairs to give a voice to our main asset: the organisations and companies that are part of the association. A new opinion forum to make us stop and reflect on the effects that changes in the environment may have on companies in the health sector. On 13 March 2024, lawmakers in the European Parliament approved by majority vote a new law to regulate AI systems, the first-ever legal framework on artificial intelligence. This is what Casper Wilstrup, CEO of Abzu, has to say on the matter.